SANA BIOTECHNOLOGY ANNOUNCES POSITIVE CLINICAL RESULTS FROM TYPE 1 DIABETES STUDY OF ISLET CELL TRANSPLANTATION WITHOUT IMMUNOSUPPRESSION

Reuters · 01/07 21:05

Please log in to view news